| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to new compounds of formula n n n n wherein: m, n, R 0 , R 1 , R 2 , R 3 and R 4 have the values presented in clause 1 of the patent claim provided the compound of formula (I) cannot represent N-methyl-1-(phenylsulphonyl)-1H-indole-4-methanamine. n EFFECT: compounds show 5-NT 6 receptor antagonist activity that that allows them being used in the pharmaceutical composition. n 19 cl, 3 tbl, 192 ex |